A Jersey legal firm has played a key role in a business deal that could transform the blood transfusion diagnostic market.
Bedell Cristin, led by partner Alasdair Hunter, advised Morgan Stanley with the issue by Quotient Limited of US$120m fixed rate senior secured loan notes due 2023 and the related security package.
Quotient, a Jersey incorporated company listed on NASDAQ, is a diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovate tests within established markets.
At the initial closing, Quotient issued US$84m of Notes with an additional US$36m of Notes to be issued upon public announcement of field trial results for MosaiQ, a next generation automation platform which it's claimed could transform the US$2.8bn blood transfusion diagnostics market.
Comments
Comments on this story express the views of the commentator only, not Bailiwick Publishing. We are unable to guarantee the accuracy of any of those comments.